Adage Capital Management is a Boston based capital management firm founded in 2001 by Phillip Gross and Robert George Atchinson.
The firm has $8.9B under its management and focuses on managing S&P 500 assets mainly for Endowments and Foundations. The firm invests in early-stage and late-stage ventures.
As of January 2020, Adage Capital Management has made 41 investments and had 28 exits.
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.
GitLab is a web-based open source Git repository manager and collaboration platform with wiki and issue tracking features and built-in CI/CD.
Tanium is a company providing security and systems management solution for businesses.
A company developing therapeutics for the treatment of cancer
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease.
ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.
Advanced Accelerator Applications is a Saint-Genis-Pouilly-based pharmaceutical company developing systems for molecular imaging and individualized therapy.
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs.
A biopharmaceutical company focused on the discovery and development of small molecule drugs to treat illnesses
A company developing small molecule drugs treat cancer
Prevail Therapeutics is a New York City-based company.
Co-Founder, Managing Director & Portfolio Manage
Daniel Joseph Lehan
Chief Operating Officer and Chief Compliance Officer
Robert George Atchinson
Co-Founder, Managing Director, and Portfolio Manager
Documentaries, videos and podcasts